Sources | Names Used |
---|---|
CCLE, GDSC1000, FIMM | Nilotinib |
CTRPv2 | nilotinib |
PharmacoGx | Nilotinib |
Database | Identifier |
---|---|
Smiles: | CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5 |
Inchikey: | HHZIURLSWUIHRB-UHFFFAOYSA-N |
Pubchem: | 644241 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FCGR2A | CTRPv2 | pan-cancer | AAC | 0.27 | 5e-13 |
mRNA | ITGA2B | GDSC1000 | pan-cancer | AAC | 0.25 | 5e-13 |
mRNA | CD33 | GDSC1000 | pan-cancer | AAC | 0.28 | 5e-13 |
mRNA | RP11-864I4.1 | CTRPv2 | pan-cancer | AAC | 0.29 | 7e-13 |
mRNA | LYL1 | CTRPv2 | pan-cancer | AAC | 0.3 | 7e-13 |
mRNA | C17orf99 | CTRPv2 | pan-cancer | AAC | 0.26 | 7e-13 |
mRNA | SLC25A21 | CTRPv2 | pan-cancer | AAC | 0.27 | 8e-13 |
mRNA | GFI1B | CCLE | pan-cancer | AAC | 0.35 | 9e-13 |
mRNA | TAL1 | CTRPv2 | pan-cancer | AAC | 0.26 | 9e-13 |
mRNA | ATP7B | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-12 |